Betamethasone Dipropionate/Clotrimazole

倍他米松二丙酸酯/克霉唑

Report date: 2022/01/14 13:23:58

Base Information

Drug NameBetamethasone Dipropionate/Clotrimazole
Drug Alias Nameclotrimazole and betamethasone dipropionate二丙酸酯倍他米松/克霉唑Betamethasone Dipropionate and ClotrimazoleClotrimazole/Betamethasone DipropionateLotrisone
ClassificationSmall molecules > Steroids
Mechanisms of ActionLanosterol 14α-demethylase inhibitorsGlucocorticoid receptor agonists
TargetsLanosterol 14α-demethylaseGlucocorticoid receptor
Therapy Area/IndicationsVulvovaginitisParonychiaTinea Versicolor +[6] 
Global Approved IndicationsVulvovaginitisParonychiaTinea Versicolor +[6] 
Approved Indications in ChinaVulvovaginitisParonychiaTinea Versicolor +[6] 
Original Approved Country/TerritoryMainland China
Original Approved Date1982/01/01
Country/TerritoryUnited StatesMainland China
CombinationsYes ClotrimazoleBetamethasone Dipropionate
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesMerck & Co Inc
China Registration ClassN/A

Develop Information

Active CompaniesTianjin Pharmaceutical Peace (Tianjin) Pharmaceutical Co Ltd
Inactive CompaniesOrganon LLC
Active IndicationsVulvovaginitisParonychiaTinea Versicolor +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeD07BC01D07CC01S01CA05 +[4] 
Related LinksKEGG